COST funds pan-European, bottom-up networks of scientists and researchers across all science and technology fields. These networks, called ‘COST Actions’, promote international coordination of nationally-funded research, but mot the research itself. Proposals for actions are now open and those which play a precursor role for other European programmes and/or initiated by early-stage researchers are favoured.COST is organised in nine broad domains (Biomedicine and Molecular Biosciences; Chemistry and Molecular Sciences and Technologies; Earth System Science and Environmental Management; Food and Agriculture; Forests, their Products and Services; Individuals, Societies, Cultures and Health; Information and Communiation Technologies; Materials, Physics and Nanosciences; Transport and Urban Development). To make a submission, you must have a minimum of five EU countries involved and you should choose one domain where possible or if it is truly interdisciplinary then there is a possibility of a trans-domain proposal application. All info on the current call can be found here.
ELOs and Sponsors
COST actions – European Cooperation in Science and Technology










REF 2029 Sector Survey: Have Your Say
BU methods paper reached 2,500 reads
UKCGE Recognised Research Supervision Programme: Applications Close 19 October
Dr. Orlanda Harvey interviewed as expert
Dr. Paul Whittington attends Technology and the SEND Reforms Roundtable in the House of Commons
Dr. Paul Whittington joins Bett 2026 DfE Assistive Technology Roundtable
Horizon Europe Cluster 3 (Civil Security for Society) 2026 Calls Now Open
MSCA Doctoral Networks 2026 Call Information Webinar
ESRC Festival of Social Science 2026: Application Deadline Extended to Thursday 25 June 2026
Reminder: Register for the ESRC Festival of Social Science 2026 Information Session
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease